Investigating the Links between Lower Iron Status in Pregnancy and Respiratory Disease in Offspring Using Murine Models.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
14 Dec 2021
Historique:
received: 24 11 2021
revised: 07 12 2021
accepted: 08 12 2021
entrez: 28 12 2021
pubmed: 29 12 2021
medline: 13 1 2022
Statut: epublish

Résumé

Maternal iron deficiency occurs in 40-50% of all pregnancies and is associated with an increased risk of respiratory disease and asthma in children. We used murine models to examine the effects of lower iron status during pregnancy on lung function, inflammation and structure, as well as its contribution to increased severity of asthma in the offspring. A low iron diet during pregnancy impairs lung function, increases airway inflammation, and alters lung structure in the absence and presence of experimental asthma. A low iron diet during pregnancy further increases these major disease features in offspring with experimental asthma. Importantly, a low iron diet increases neutrophilic inflammation, which is indicative of more severe disease, in asthma. Together, our data demonstrate that lower dietary iron and systemic deficiency during pregnancy can lead to physiological, immunological and anatomical changes in the lungs and airways of offspring that predispose to greater susceptibility to respiratory disease. These findings suggest that correcting iron deficiency in pregnancy using iron supplements may play an important role in preventing or reducing the severity of respiratory disease in offspring. They also highlight the utility of experimental models for understanding how iron status in pregnancy affects disease outcomes in offspring and provide a means for testing the efficacy of different iron supplements for preventing disease.

Identifiants

pubmed: 34960012
pii: nu13124461
doi: 10.3390/nu13124461
pmc: PMC8708709
pii:
doi:

Substances chimiques

Egg Proteins, Dietary 0
Collagen 9007-34-5
Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Am J Respir Crit Care Med. 2017 Aug 1;196(3):283-297
pubmed: 28252317
Acta Paediatr. 1996 Nov;85(11):1327-30
pubmed: 8955460
Pediatr Pulmonol. 2020 Jan;55(1):229-235
pubmed: 31535471
Free Radic Biol Med. 2019 Mar;133:238-247
pubmed: 30075191
Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L557-67
pubmed: 17545484
Am J Respir Cell Mol Biol. 2021 Aug;65(2):189-200
pubmed: 33861690
Gut. 2020 Jan;69(1):42-51
pubmed: 31036757
Eur Respir J. 2004 Aug;24(2):292-7
pubmed: 15332400
Clin Exp Allergy. 2017 Dec;47(12):1615-1624
pubmed: 28940397
EBioMedicine. 2017 Jun;20:230-239
pubmed: 28499927
Front Med (Lausanne). 2021 May 31;8:674324
pubmed: 34136507
J Allergy Clin Immunol. 2021 Oct 19;:
pubmed: 34678326
Crit Rev Food Sci Nutr. 2021 Oct 6;:1-31
pubmed: 34613853
J Allergy Clin Immunol. 2018 Feb;141(2):560-570
pubmed: 28528200
Ann N Y Acad Sci. 2010 Aug;1203:23-8
pubmed: 20716279
J Infect Dis. 2021 Oct 13;224(7):1236-1246
pubmed: 32239170
J Allergy Clin Immunol. 2017 Feb;139(2):519-532
pubmed: 27448447
Appl Environ Microbiol. 2021 Jan 15;87(3):
pubmed: 33188000
J Allergy Clin Immunol. 2010 Mar;125(3):617-25, 625.e1-625.e6
pubmed: 20122715
Eur Respir J. 2020 Apr 23;55(4):
pubmed: 32184317
Am J Med. 2001 Oct 15;111(6):439-45
pubmed: 11690568
PLoS One. 2013 Sep 06;8(9):e74101
pubmed: 24040180
J Perinatol. 2015 Aug;35(8):621-6
pubmed: 25836316
Therap Adv Gastroenterol. 2011 May;4(3):177-84
pubmed: 21694802
Thorax. 2015 May;70(5):458-67
pubmed: 25746630
Am J Respir Crit Care Med. 2001 Nov 1;164(9):1718-21
pubmed: 11719315
Int J Biochem Cell Biol. 2017 Jul;88:181-195
pubmed: 28495571
J Trop Pediatr. 2009 Oct;55(5):324-7
pubmed: 19261662
Ann Allergy Asthma Immunol. 2011 Feb;106(2):131-139.e1
pubmed: 21277514
Am J Respir Cell Mol Biol. 2021 Aug;65(2):130-131
pubmed: 33945773
J Pathol. 2020 May;251(1):49-62
pubmed: 32083318
Saudi Med J. 2015 Feb;36(2):146-9
pubmed: 25719576
BMJ Open Respir Res. 2018 Mar 30;5(1):e000275
pubmed: 29636978
Thorax. 2002 Apr;57(4):309-16
pubmed: 11923548

Auteurs

Henry M Gomez (HM)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

Amber L Pillar (AL)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

Alexandra C Brown (AC)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

Richard Y Kim (RY)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.
Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW 2007, Australia.

Md Khadem Ali (MK)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

Ama-Tawiah Essilfie (AT)

QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.

Rebecca L Vanders (RL)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

David M Frazer (DM)

QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
School of Biomedical Sciences, The University of Queensland, St Lucia, QLD 4067, Australia.

Gregory J Anderson (GJ)

QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
School of Chemistry and Molecular Bioscience, The University of Queensland, St Lucia, QLD 4067, Australia.

Philip M Hansbro (PM)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.
Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, NSW 2007, Australia.

Adam M Collison (AM)

School of Medicine and Public Health, College of Health, Medicine and Wellbeing, and Priority Research Centre for GrowUpWell, The University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

Megan E Jensen (ME)

School of Medicine and Public Health, College of Health, Medicine and Wellbeing, and Priority Research Centre for GrowUpWell, The University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

Vanessa E Murphy (VE)

School of Medicine and Public Health, College of Health, Medicine and Wellbeing, and Priority Research Centre for GrowUpWell, The University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

Daniel M Johnstone (DM)

School of Medical Sciences, University of Sydney, Camperdown, NSW 2050, Australia.

David Reid (D)

QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.

Elizabeth A Milward (EA)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

Chantal Donovan (C)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.
Faculty of Science, School of Life Sciences, University of Technology Sydney, Sydney, NSW 2007, Australia.

Jay C Horvat (JC)

School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, and Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW 2308, Australia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH